DHR · Danaher Corp · Webcasts, Transcripts & Audio
$229.91
-5.02 (-2.14%)
At close · Nov 5
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$165.28B
Shares
703.53M
Volume · Nov 5
1.51M
Avg daily vol (3M)
3.94M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Danaher Corp Webcasts
Earnings calls, investor updates, investor days and conferences for Danaher Corp (DHR), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q3
2026-10-21
Danaher Corp (DHR) Q3 2026 Earnings Call Transcript
Confident tone
Diagnostics performance and respiratory headwind
Third-quarter performance and outlook
Portfolio integration and cross-business collaboration
Revenue
$6.55B
▲ 8.3% YoY Diluted EPS
$1.75
▲ 37.8% YoY Gross margin
58.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-07-21
Danaher Corp (DHR) Q2 2026 Earnings Call Transcript
Positive tone
Bioprocessing shipment delays and rebase
Order book strength and reshoring
Customer demand and end-market commentary
Revenue
$6.26B
▲ 5.5% YoY Diluted EPS
$1.23
▲ 59.7% YoY Gross margin
57.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-04-21
Danaher Corp (DHR) Q1 2026 Earnings Call Transcript
Positive tone
Masimo acquisition and capital deployment
Respiratory weakness at Cepheid
China end markets
Revenue
$5.95B
▲ 3.7% YoY Diluted EPS
$1.45
▲ 9.8% YoY Gross margin
60.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-01-28
Danaher Corp (DHR) Q4 2025 Earnings Call Transcript
Positive tone
Bioprocessing momentum
Pharma R&D and capital spending recovery
Academic and government softness
Revenue
$6.84B*
▲ 4.6% YoY Gross margin
58.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-21
Danaher Corp (DHR) Q3 2025 Earnings Call Transcript
Positive tone
China market headwinds and localization
Bioprocessing / monoclonal antibodies demand
Innovation and product launches
Revenue
$6.05B
▲ 4.4% YoY Diluted EPS
$1.27
▲ 13.4% YoY Gross margin
58.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-22
Danaher Corp (DHR) Q2 2025 Earnings Call Transcript
Balanced tone
Bioprocessing / Biotech Performance
China and Geographies
Diagnostics / Cepheid Respiratory and Non-Respiratory
Revenue
$5.94B
▲ 3.4% YoY Diluted EPS
$0.77
▼ 36.9% YoY Gross margin
59.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-22
Danaher Corp (DHR) Q1 2025 Earnings Call Transcript
Positive tone
China and volume-based procurement
Bioprocessing momentum
Macro and trade uncertainty
Revenue
$5.74B
▼ 0.9% YoY Diluted EPS
$1.32
▼ 9% YoY Gross margin
61.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-01-13
Danaher Corp (DHR) Q4 2024 Earnings Call Transcript
Positive tone
Bioprocessing recovery and momentum
Diagnostics and respiratory season
China headwinds
Revenue
$6.54B*
▲ 2.1% YoY Gross margin
59.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-22
Danaher Corp (DHR) Q3 2024 Earnings Call Transcript
Positive tone
China weakness and stimulus uncertainty
Bioprocessing recovery
2025 outlook and DBS savings
Revenue
$5.80B
▲ 3.1% YoY Diluted EPS
$1.12
▼ 25.8% YoY Gross margin
58.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-23
Danaher Corp (DHR) Q2 2024 Earnings Call Transcript
Positive tone
Bioprocessing recovery
China weakness and stimulus
Diagnostics and Cepheid
Revenue
$5.74B
▼ 2.9% YoY Diluted EPS
$1.22
▼ 18.1% YoY Gross margin
59.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-04-23
Danaher Corp (DHR) Q1 2024 Earnings Call Transcript
Confident tone
Bioprocessing recovery
M&A and capital deployment
Large pharma demand
Revenue
$5.80B
▼ 2.6% YoY Diluted EPS
$1.45
▼ 25.3% YoY Gross margin
60.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-01-30
Danaher Corp (DHR) Q4 2023 Earnings Call Transcript
Balanced tone
2024 guidance and outlook
Bioprocessing destocking and recovery
Diagnostics and Cepheid respiratory
Revenue
$6.41B
▼ 10.2% YoY Diluted EPS
$1.45
▼ 51.5% YoY Gross margin
59.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-10-24
Danaher Corp (DHR) Q3 2023 Earnings Call Transcript
Revenue
$5.62B
▼ 12.9% YoY Diluted EPS
$1.51
▼ 28.1% YoY Gross margin
58.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-07-25
Danaher Corp (DHR) Q2 2023 Earnings Call Transcript
Revenue
$5.91B
▼ 9.4% YoY Diluted EPS
$1.49
▼ 33.8% YoY Gross margin
56.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-04-25
Danaher Corp (DHR) Q1 2023 Earnings Call Transcript
Revenue
$5.95B
▼ 8.8% YoY Diluted EPS
$1.94
▼ 16% YoY Gross margin
61.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-01-09
Danaher Corp (DHR) Q4 2022 Earnings Call Transcript
Revenue
$7.13B
▲ 104% YoY Diluted EPS
$2.99
Gross margin
59.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-10-20
Danaher Corp (DHR) Q3 2022 Earnings Call Transcript
Revenue
$6.46B
▼ 10.7% YoY Diluted EPS
$2.10
▲ 36.4% YoY Gross margin
60.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-07-21
Danaher Corp (DHR) Q2 2022 Earnings Call Transcript
Revenue
$6.53B
▼ 9.6% YoY Diluted EPS
$2.25
▼ 6.2% YoY Gross margin
61.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-04-21
Danaher Corp (DHR) Q1 2022 Earnings Call Transcript
Revenue
$6.53B
▼ 4.8% YoY Diluted EPS
$2.31
▲ 0.9% YoY Gross margin
62.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-01-27
Danaher Corp (DHR) Q4 2021 Earnings Call Transcript
Revenue
$3.50B*
▼ 48.3% YoY Gross margin
63.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-10-21
Danaher Corp (DHR) Q3 2021 Earnings Call Transcript
Revenue
$7.23B
▲ 22.9% YoY Diluted EPS
$1.54
▲ 32.8% YoY Gross margin
60.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-22
Danaher Corp (DHR) Q2 2021 Earnings Call Transcript
Revenue
$7.22B
▲ 36.3% YoY Diluted EPS
$2.40
▲ 93.5% YoY Gross margin
60.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-04-22
Danaher Corp (DHR) Q1 2021 Earnings Call Transcript
Revenue
$6.86B
▲ 57.9% YoY Diluted EPS
$2.29
▲ 182.7% YoY Gross margin
62.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-01-13
Danaher Corp (DHR) Q4 2020 Earnings Call Transcript
Revenue
$6.76B*
▲ 38.9% YoY Gross margin
58.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-22
Danaher Corp (DHR) Q3 2020 Earnings Call Transcript
Revenue
$5.88B
▲ 34.4% YoY Diluted EPS
$1.16
▲ 30.3% YoY Gross margin
54.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-23
Danaher Corp (DHR) Q2 2020 Earnings Call Transcript
Revenue
$5.30B
▲ 19.2% YoY Diluted EPS
$1.24
▲ 27.8% YoY Gross margin
53.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-13
Danaher Corp (DHR) Q1 2020 Earnings Call Transcript
Revenue
$4.34B
▲ 2.9% YoY Diluted EPS
$0.81
▲ 76.1% YoY Gross margin
56.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-01-13
Danaher Corp (DHR) Q4 2019 Earnings Call
Revenue
$4.87B
▼ 9.2% YoY Diluted EPS
$1.73
▲ 64.8% YoY Gross margin
55.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–28 of 28 webcasts
Key facts
CIK
313616
CUSIP
235851102
13F (30d)
1142 filings
1044 filers
Visit website
Investor relations